Management of methicillin-resistant Staphylococcus aureus infections.
This review addresses selected aspects of the management of severe healthcare-associated infections due to methicillin-resistant Staphylococcus aureus (MRSA), including the limitations of current therapy, potential alternative agents, new therapeutic options, clinical approaches to MRSA bacteraemia/endocarditis and ventilator-associated pneumonia, and strategies to improve outcomes in patients with severe MRSA infections.
Garau
J
J
Department of Medicine, Hospital Universitari Mutua de Terrassa, Terrassa, Barcelona, Spain. xgarau@mutuaterrassa.es
Bouza
E
E
Chastre
J
J
Gudiol
F
F
Harbarth
S
S
D019090:Case Management; D003428:Cross Infection / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification*; D013203:Staphylococcal Infections / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology